Brief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
01/06/2026 01:01
BRIEF-Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share May 31 (Reuters) - Briacell Therapeutics Corp BCT.TO:
BRIACELL THERAPEUTICS ANNOUNCES PRICING OF OFFERING
BRIACELL THERAPEUTICS - ANNOUNCES PRICING OF OFFERING OF 1.45 MILLION COMMON SHARES AT $3.25 PER SHARE
Source text: ID:nGNX8NBN4W
Further company coverage: BCT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study